Exclusion Criteria:~* Any cause of dementia not due to Alzheimer's disease, Delusions, delirium, psychosis,
depression, or other significant psychiatric disorder.~* Treatment with any registered or putative cognitive
enhancer or disease modifier other than donepezil, rivastigmine or galantamine.~* Females who are pregnant or
breast-feeding. Females of child bearing potential (premenopausal female biologically capable of becoming
pregnant) must have a confirmed negative serum b-HCG pregnancy test at the screening visit, and must use an
acceptable method of birth control.~* Severe or unstable cardiovascular, respiratory, renal, hematological,
endocrinological, neurological or other somatic disease.~* Use of CYP3A4 strong inhibitors~* Evidence (detected
by history, physical examination and / or laboratory / ECG tests) of any clinically significant or unstable
medical disorder that could interfere with the subject's participation in the clinical trial; interfere with
the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study
drug. Alterations of laboratory tests or ECG findings of potential clinical significance.
